Identification of therapeutic small-molecule leads in cultured cells using multiplexed pathway reporter readouts

Ozlem Kulak, Kiyoshi Yamaguchi, Lawrence Lum

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The rapid expansion of molecular screening libraries in size and complexity in the last decade has outpaced the discovery rate of cost-effective strategies to single out reagents with sought-after cellular activities. In addition to representing high-priority therapeutic targets, intensely studied cell signaling systems encapsulate robust reference points for mapping novel chemical activities given our deep understanding of the molecular mechanisms that support their activity. In this chapter, we describe strategies for using transcriptional reporters of several well-interrogated signal transduction pathways coupled with high-throughput biochemical assays to fingerprint novel compounds for drug target identification agendas.

Original languageEnglish (US)
Pages (from-to)3-16
Number of pages14
JournalMethods in Molecular Biology
Volume1263
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Dermatoglyphics
Libraries
Cultured Cells
Signal Transduction
Costs and Cost Analysis
Pharmaceutical Preparations
Therapeutics

Keywords

  • Dot blotting
  • Kras
  • Luciferase assay
  • RNAi
  • Small-molecule screening
  • TP53
  • Wnt

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Identification of therapeutic small-molecule leads in cultured cells using multiplexed pathway reporter readouts. / Kulak, Ozlem; Yamaguchi, Kiyoshi; Lum, Lawrence.

In: Methods in Molecular Biology, Vol. 1263, 01.01.2015, p. 3-16.

Research output: Contribution to journalArticle

@article{1755f6fbfd814a5ebd381fb63e21f9c4,
title = "Identification of therapeutic small-molecule leads in cultured cells using multiplexed pathway reporter readouts",
abstract = "The rapid expansion of molecular screening libraries in size and complexity in the last decade has outpaced the discovery rate of cost-effective strategies to single out reagents with sought-after cellular activities. In addition to representing high-priority therapeutic targets, intensely studied cell signaling systems encapsulate robust reference points for mapping novel chemical activities given our deep understanding of the molecular mechanisms that support their activity. In this chapter, we describe strategies for using transcriptional reporters of several well-interrogated signal transduction pathways coupled with high-throughput biochemical assays to fingerprint novel compounds for drug target identification agendas.",
keywords = "Dot blotting, Kras, Luciferase assay, RNAi, Small-molecule screening, TP53, Wnt",
author = "Ozlem Kulak and Kiyoshi Yamaguchi and Lawrence Lum",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-1-4939-2269-7_1",
language = "English (US)",
volume = "1263",
pages = "3--16",
journal = "Methods in molecular biology (Clifton, N.J.)",
issn = "1064-3745",
publisher = "Humana Press",

}

TY - JOUR

T1 - Identification of therapeutic small-molecule leads in cultured cells using multiplexed pathway reporter readouts

AU - Kulak, Ozlem

AU - Yamaguchi, Kiyoshi

AU - Lum, Lawrence

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The rapid expansion of molecular screening libraries in size and complexity in the last decade has outpaced the discovery rate of cost-effective strategies to single out reagents with sought-after cellular activities. In addition to representing high-priority therapeutic targets, intensely studied cell signaling systems encapsulate robust reference points for mapping novel chemical activities given our deep understanding of the molecular mechanisms that support their activity. In this chapter, we describe strategies for using transcriptional reporters of several well-interrogated signal transduction pathways coupled with high-throughput biochemical assays to fingerprint novel compounds for drug target identification agendas.

AB - The rapid expansion of molecular screening libraries in size and complexity in the last decade has outpaced the discovery rate of cost-effective strategies to single out reagents with sought-after cellular activities. In addition to representing high-priority therapeutic targets, intensely studied cell signaling systems encapsulate robust reference points for mapping novel chemical activities given our deep understanding of the molecular mechanisms that support their activity. In this chapter, we describe strategies for using transcriptional reporters of several well-interrogated signal transduction pathways coupled with high-throughput biochemical assays to fingerprint novel compounds for drug target identification agendas.

KW - Dot blotting

KW - Kras

KW - Luciferase assay

KW - RNAi

KW - Small-molecule screening

KW - TP53

KW - Wnt

UR - http://www.scopus.com/inward/record.url?scp=84922032208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922032208&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-2269-7_1

DO - 10.1007/978-1-4939-2269-7_1

M3 - Article

C2 - 25618332

AN - SCOPUS:84922032208

VL - 1263

SP - 3

EP - 16

JO - Methods in molecular biology (Clifton, N.J.)

JF - Methods in molecular biology (Clifton, N.J.)

SN - 1064-3745

ER -